Aethlon Medical director granted 21,815 RSUs

Rossetti Angela reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Rossetti Angela reported acquisition or exercise transactions in this Form 4 filing.

Aethlon Medical director Angela Rossetti received an equity award of 21,815 shares of Common Stock at $2.29 per share. The award is structured as RSUs that vest in four equal quarterly installments on June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, contingent on her continued service. Following this grant, she directly owns 26,207 shares.

Insider Trade Summary

Grant/Award: 21,815 shares

Grant/Award 1 txn

Insider Rossetti Angela

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	21,815	$2.29	$50K

Holdings After Transaction: Common Stock — 26,207 shares (Direct)

Footnotes (1)

1. F1. The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the Reporting Person's continued service with the Company on each such vesting date.

Key Figures

RSU grant size: 21,815 shares Grant price: $2.29 per share Post-transaction holdings: 26,207 shares +2 more

5 metrics

RSU grant size 21,815 shares Grant/award acquisition reported for Angela Rossetti

Grant price $2.29 per share Price per share for RSU grant

Post-transaction holdings 26,207 shares Direct Common Stock held after the grant

First vesting date June 30, 2026 First of four equal quarterly RSU vesting dates

Final vesting date March 31, 2027 Last scheduled RSU vesting date, subject to continued service

Key Terms

RSUs, vesting, quarterly installments, continued service

4 terms

RSUs financial

"The Reporting Person was granted RSUs that vest in four equal quarterly installments"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

vesting financial

"RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

quarterly installments financial

"granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027"

continued service financial

"subject to the Reporting Person's continued service with the Company on each such vesting date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Aethlon Medical (AEMD) report for Angela Rossetti?

Aethlon Medical reported that director Angela Rossetti received a grant of 21,815 shares of Common Stock at $2.29 per share. The grant is in the form of RSUs, which convert into shares as they vest over time, subject to continued service.

How many Aethlon Medical (AEMD) shares does Angela Rossetti hold after this Form 4 transaction?

After the reported transaction, Angela Rossetti directly holds 26,207 shares of Aethlon Medical Common Stock. This total reflects the newly granted 21,815 shares, structured as RSUs, combined with her existing holdings reported in the filing.

What is the vesting schedule for Angela Rossetti’s RSU grant at Aethlon Medical (AEMD)?

The RSU grant to Angela Rossetti vests in four equal quarterly installments. Vesting dates are June 30, 2026, September 30, 2026, December 31, 2026, and March 31, 2027, and each installment requires her continued service with Aethlon Medical on the relevant vesting date.

Was Angela Rossetti’s Aethlon Medical (AEMD) Form 4 transaction a market purchase or a grant?

The Form 4 reports a grant or award acquisition, not a market purchase. Angela Rossetti received 21,815 RSUs at $2.29 per share as part of her compensation, which vest over time instead of being bought on the open market.

What type of security did Angela Rossetti receive in the Aethlon Medical (AEMD) Form 4 filing?

The filing shows Angela Rossetti received Common Stock in the form of RSUs. These restricted stock units represent 21,815 shares at $2.29 per share and will convert into actual shares as they vest on the scheduled quarterly dates, assuming continued service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/21/2026 - 05:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rossetti Angela

(Last) (First) (Middle)

11555 SORRENTO VALLEY ROAD, STE 203

(Street)

SAN DIEGO CALIFORNIA 92121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AETHLON MEDICAL INC [ AEMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/17/2026		A		21,815(1)	A	$2.29	26,207	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person was granted RSUs that vest in four equal quarterly installments on each of June 30, 2026, September 30, 2026, December 31, 2026 and March 31, 2027, subject to the Reporting Person's continued service with the Company on each such vesting date.

	/s/ Angela Rossetti by: James B. Frakes, Attorney-in-fact	04/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)